World Cancer Day 2019: Education and Inspiration Around the Globe

On February 4, 2019, organizations around the globe will come together to recognize World Cancer Day, bringing awareness to the immense burden of cancer that continues to be felt throughout the world. Joining the global community in showing support to all those affected by cancer, the American Association for Cancer Research (AACR) raises awareness about cancer and cancer research by educating the public about cancer, both in the United States and internationally.

Read More

Gauging Progress Against Cervical Cancer

January is Cervical Cancer Awareness Month. Given that January was named after the Roman god Janus, whose two faces allowed him to look both backward into the old year and forward into the new one, it seemed a good time to look back at the progress we made against cervical cancer in 2018 and to look for ways to build on the progress and further reduce the incidence and mortality of the disease in the future.

Read More

Recent FDA Approvals Signal More Progress Against Cancer

The past month has seen the U.S. Food and Drug Administration (FDA) expand the use of four anticancer therapeutics, providing new treatment options for patients with four types of cancer. On Aug. 16, 2018, the agency approved the immunotherapeutic nivolumab (Opdivo) for treating certain patients with small cell lung cancer and approved the molecularly targeted therapeutic lenvatinib (Lenvima) for treating certain patients with the most common type of liver cancer, hepatocellular carcinoma.

Read More

An Important Skin Cancer Prevention Reminder: Don’t Fry

Skin cancer is the most commonly diagnosed cancer in the United States. Every year, about 5 million Americans are treated for various forms of the disease.

Skin cancer types include basal and squamous cell cancers, as well as melanoma, the deadliest form of skin cancer. About 73,870 Americans are expected to be diagnosed with melanoma this year. Survival rates are significantly higher when the disease is diagnosed at its earliest stage.

Read More

Why Is Liver Cancer on the Rise?

Although liver cancer isn’t as prevalent as lung cancer or breast cancer, this cancer is now the fastest-increasing cause of cancer death in the United States. In the Spring 2018 issue of Cancer Today, contributing editor Sue Rochman explored contributing factors for the increased liver cancer incidence since the mid-1970s.

Read More

AICR Guest Post: Healthy Habits to Lower Cancer Risk

Editor’s note: February is Cancer Prevention Month. That’s why the American Association for Cancer Research (AACR) has been pleased to support the American Institute for Cancer Research (AICR) Cancer Prevention: Together We Can campaign, an initiative dedicated to promoting evidence-based information to reduce cancer risk. This blog post was developed and shared by the AICR.

Read More

Why We Need Tailored Tobacco-control Strategies

Cigarette smoking is linked to 18 different types of cancer. It is the leading preventable cause of cancer in the United States, accounting for 19 percent of the 1,570,978 cancers diagnosed in U.S. adults ages 30 and older in 2014, according to the latest research. Another 0.4 percent of the cancer diagnoses in the U.S. that year were attributable to exposure to secondhand smoke.

That’s why February, which is National Cancer Prevention Month, is a good time to raise awareness of the dangers of cigarette smoking and exposure to secondhand smoke.

Read More

Advances in Tobacco Control

Cigarette smoking is the leading cause of death from lung cancer in the United States. That’s why November, Lung Cancer Awareness Month, is a good time to highlight new advances in tobacco control, such as the legislation that came into effect Nov. 1, 2017, in New Jersey that raises the minimum age of legal access to tobacco products to 21.

Read More

Understanding Premalignancy and Cancer Risk

Prevention is often said to be more powerful than a cure. With an eye toward thwarting the disease, some researchers are trying to understand the molecular processes that are present in cells before cancer develops. These efforts, which analyze the potential power of premalignancy, are featured in the spring issue of Cancer Today.

Read More